LACY KUSY: Open Payments
NPI 1700249596 · PENSACOLA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$266 in 14 payments from 8 companies in 2025. Trend: 2023 $1,616 · 2024 $1,844 · 2025 $266
Food & beverage: $266
| Company | Payments | Amount |
|---|---|---|
| BETA BIONICS, INC. | 3 | $54 |
| Boston Scientific Corporation | 3 | $54 |
| Medtronic, Inc. | 2 | $38 |
| Novo Nordisk Inc | 2 | $38 |
| Dexcom, Inc. | 1 | $30 |
| Corcept Therapeutics | 1 | $18 |
| Lilly USA, LLC | 1 | $17 |
| Tandem Diabetes Care, Inc. | 1 | $17 |
Products named: iLet Bionic Pancreas, MINIMED 780G, Ozempic, WATCHMAN, Dexcom G6 Transmitter, Korlym, WATCHMAN FLX, JARDIANCE.
Industry payments across FL — which companies pay providers there.
